Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
309 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
Dittmer selected to serve as chair of AIDS-Associated Opportunistic Infections and Cancer Study Section
by Mary Ruth published Jul 21, 2012 last modified Jul 20, 2012 09:28 AM — filed under: ,
Dirk Dittmer, PhD, professor of microbiology and immunology, has been selected to serve as chair of the AIDS-Associated Opportunistic Infections and Cancer Study Section, for the Center for Scientific Review, a program of the National Institutes of Health.
Located in News / 2012 News
“Corona Cares” supports patients, families dealing with cancer
by Mary Ruth published Jul 19, 2012 last modified Jul 19, 2012 09:08 AM — filed under: ,
RALEIGH, NC – Crown Imports announced today that the highly successful “Corona Cares” charitable donation program in North Carolina will kick off on August 1 to benefit patient and family support programs at the N.C. Cancer Hospital. Over the past two years, “Corona Cares” has provided more than $210,000 for these programs.
Located in News / 2012 News
Study shows colon and rectal tumors constitute a single type of cancer
by Mary Ruth published Jul 18, 2012 last modified Aug 14, 2012 02:34 PM — filed under: ,
The Cancer Genome Atlas generates genomic data for colon and rectal cancers that point to potential targets for treatment.
Located in News / 2012 News
Pox, patents and pancreatic cancer vaccines
by Mary Ruth published Jul 17, 2012 last modified Jul 18, 2012 01:32 PM — filed under: ,
Rachel Roper, PhD, Associate Professor of Microbiology & Immunology at East Carolina’s Brody School of Medicine has been granted a patent for her discovery of a poxvirus gene that, when deleted, significantly weakens the vaccine virus while simultaneously increasing immune responses to it.
Located in News / 2012 News
Cancer one of three UNC specialties nationally ranked by U.S. News
by Mary Ruth published Jul 17, 2012 last modified Jul 17, 2012 03:14 PM — filed under: ,
Overall, eleven specialties at UNC Hospitals were recognized as nationally ranked or high performing by U.S. News & World Report in its annual "America's Best Hospitals" issue.
Located in News / 2012 News
Kenan Institute appoints Joseph DeSimone as new director
by Mary Ruth published Jul 17, 2012 last modified Jul 17, 2012 09:18 AM — filed under: ,
The University of North Carolina at Chapel Hill’s Frank Hawkins Kenan Institute of Private Enterprise has appointed Joseph M. DeSimone as its new director.
Located in News / 2012 News
Amos quoted in ABC News feature
by Mary Ruth published Jul 13, 2012 last modified Jul 13, 2012 10:55 AM — filed under: , ,
Keith Amos, MD, assistant professor of surgery at UNC-Chapel Hill, is quoted in an ABC News feature discussing a new study about partial breast removal surgery to treat cancer.
Located in News / 2012 News
Strader honored by Leukemia & Lymphoma Society
by Mary Ruth published Jul 11, 2012 last modified Jul 11, 2012 03:44 PM — filed under: , ,
John Strader, PA-C with the hematologic malignancies program, was honored as the 2012 Man of the Year by the Leukemia & Lymphoma Society, North Carolina chapter, raising over $30,000 for the organization.
Located in News / 2012 News
Preclinical studies use specialized ultrasound to detect presence of cancer
by Mary Ruth published Jul 10, 2012 last modified Jul 17, 2012 11:50 AM — filed under: ,
Chapel Hill - From the air, the twists and turns of rivers can easily be seen. In the body, however, tracing the twists and turns of blood vessels is difficult, but important. Vessel “bendiness” can indicate the presence and progression of cancer.
Located in News / 2012 News
Key biomarker’s new role in head and neck cancer
by Mary Ruth published Jul 06, 2012 last modified Jul 10, 2012 12:27 PM — filed under: , ,
Researchers at UNC have proposed a novel interpretation of an old biomarker which, if validated, could fundamentally transform the management of head and neck cancer.
Located in News / 2012 News